Developer docs
API playgroundTry for free, no card

Search company profiles

CG Life

Full company profile

uuid0008ctf

Namestring
CG Life
Legal namestring
The Chempetitive Group LLC
Websiteurl
cglife.com
Company typeenum
Private
Founded yearint
2000
Descriptiontext

CG Life (legal entity: The Chempetitive Group LLC) is a privately held life sciences marketing and communications agency founded in 2003 and headquartered in Chicago, Illinois, with additional offices in San Diego and New York. The firm is specialized in serving biotechnology and pharmaceutical companies developing therapies for rare and hard-to-treat diseases, operating across seven integrated service lines: brand strategy, public relations and social media, creative, omnichannel strategy and enablement, scientific communications, media planning, and analytics and insights. A team of 150+ specialists is organized into 8 integrated departments and includes embedded scientific ambassadors who translate complex science into marketing communications for healthcare providers, patients, and caregivers.

The agency's go-to-market is consultative enterprise field sales targeting biopharma marketing leadership, supported by thought leadership content (e.g., the SightLines blog series), industry events (including Social Media Week), and inbound interest from clients seeking rare disease commercialization expertise. Revenue is generated through project-based engagements, retainer agreements, and hourly consulting fees typical of professional services firms, with pricing quoted per project scope and engagement complexity. The firm has pursued an active roll-up strategy, acquiring The Market Element (January 2020), McDAY (April 2020), Toolhouse (April 2024, which doubled staff), and Berry & Company Public Relations (May 2024), consolidating its position as an integrated healthcare communications provider.

In 2026, the company launched the 24/364 cultural brand platform, a year-round storytelling, film, and film festival initiative for rare disease awareness, and joined the American Biotech Innovation Alliance (ABIA) as a founding member. Leadership was also expanded, with Coco Douaihy (formerly of Dentsu International) appointed Chief Creative Officer and Chris Weber promoted to Chief Strategy Officer. A January 2023 funding round led by Shore Capital Partners is disclosed, supporting the firm's growth and acquisition agenda.

Short descriptiontext

CG Life is a privately held life sciences marketing and communications agency that provides integrated brand strategy, public relations, creative, omnichannel, scientific communications, media planning, and analytics services to biotech and pharmaceutical companies developing therapies for rare and hard-to-treat diseases.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersChicago, United States
HQ citystring
Chicago
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
life sciences marketing, biotech communications, rare disease branding, pharmaceutical marketing, healthcare public relations
Industry2 codes
PRIMARYMPAAADAD
Healthcare & Life Sciences PR
Media, Entertainment & Sports/Advertising, Marketing & PR Services/Public Relations & Communications Agencies
SECONDARYBPAFADAJ
Healthcare & Life Sciences PR
NAICS code2 codes
  • Advertising Agencies541810
  • Advertising, Public Relations, and Related Services5418
Product category
Life Sciences Marketing Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Marketing Communications Services
TypeProfessional Services
Description

CG Life generates revenue through providing integrated marketing communications services to life sciences companies. Services include brand strategy, public relations, social media, creative development, omnichannel strategy, scientific communications, media planning, and analytics. Revenue is generated through project-based engagements, retainer agreements, and hourly consulting fees typical of professional services agencies serving the biopharmaceutical industry.

cglife.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details1 tier
1Professional agency services for life sciences clients
ModelOtherBilling cadenceMulti-year contract
Notes

Agency services are quoted based on project scope, staffing requirements, and engagement complexity. No public pricing tiers available.

cglife.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
124/364
Description

A cultural brand platform created by CG Life to drive rare disease awareness, connection, and action year-round, featuring storytelling, films, and a film festival.

businesswire.com
Core offering1 text field

CG Life is an integrated marketing communications agency that provides branding, public relations, social media, creative development, omnichannel strategy, scientific communications, media planning, and analytics services to biotech and pharmaceutical companies specializing in rare and hard-to-treat diseases. The agency guides precision medicine innovators from clinical development through commercial launch with deep scientific expertise embedded across its service delivery.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

CG Life is a life sciences marketing agency specialized for rare and hard-to-treat diseases, offering integrated marketing communications services. The agency's portfolio consists of seven core service offerings: Brand Strategy, Public Relations & Social Media, Creative, Omnichannel Strategy & Enablement, Scientific Communications, Media Planning, and Analytics & Insights. These services work together to help biotech and pharmaceutical companies navigate the path from clinical development to commercial launch. The agency has also developed the 24/364 Brand Platform, a cultural initiative featuring storytelling and films to maintain year-round visibility for rare diseases. CG Life has expanded its capabilities through strategic acquisitions of Berry & Company Public Relations (healthcare communications) and Toolhouse (digital marketing for biopharma), integrating them into its service delivery model.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-01
Description

CG Life is a founding member of the American Biotech Innovation Alliance (ABIA), joining biotechnology leaders from across the country to define a long-term national strategy to sustain and extend U.S. leadership in global biotech innovation. CG Life supported the alliance's launch through strategic communications and contributes to collaborative efforts shaping biotech policy and innovation strategy.

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Strengths1 record

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles17 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A5 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CG Life

Life Sciences Marketing Servicescglife.com

CG Life is a privately held life sciences marketing and communications agency that provides integrated brand strategy, public relations, creative, omnichannel, scientific communications, media planning, and analytics services to biotech and pharmaceutical companies developing therapies for rare and hard-to-treat diseases.

What CG Life does

CG Life (legal entity: The Chempetitive Group LLC) is a privately held life sciences marketing and communications agency founded in 2003 and headquartered in Chicago, Illinois, with additional offices in San Diego and New York. The firm is specialized in serving biotechnology and pharmaceutical companies developing therapies for rare and hard-to-treat diseases, operating across seven integrated service lines: brand strategy, public relations and social media, creative, omnichannel strategy and enablement, scientific communications, media planning, and analytics and insights. A team of 150+ specialists is organized into 8 integrated departments and includes embedded scientific ambassadors who translate complex science into marketing communications for healthcare providers, patients, and caregivers.

The agency's go-to-market is consultative enterprise field sales targeting biopharma marketing leadership, supported by thought leadership content (e.g., the SightLines blog series), industry events (including Social Media Week), and inbound interest from clients seeking rare disease commercialization expertise. Revenue is generated through project-based engagements, retainer agreements, and hourly consulting fees typical of professional services firms, with pricing quoted per project scope and engagement complexity. The firm has pursued an active roll-up strategy, acquiring The Market Element (January 2020), McDAY (April 2020), Toolhouse (April 2024, which doubled staff), and Berry & Company Public Relations (May 2024), consolidating its position as an integrated healthcare communications provider.

In 2026, the company launched the 24/364 cultural brand platform, a year-round storytelling, film, and film festival initiative for rare disease awareness, and joined the American Biotech Innovation Alliance (ABIA) as a founding member. Leadership was also expanded, with Coco Douaihy (formerly of Dentsu International) appointed Chief Creative Officer and Chris Weber promoted to Chief Strategy Officer. A January 2023 funding round led by Shore Capital Partners is disclosed, supporting the firm's growth and acquisition agenda.

CG Life firmographics

Firmographics
Name
CG Life
Legal name
The Chempetitive Group LLC
Website
https://cglife.com
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
101–250 employees
Short description
CG Life is a privately held life sciences marketing and communications agency that provides integrated brand strategy, public relations, creative, omnichannel, scientific communications, media planning, and analytics services to biotech and pharmaceutical companies developing therapies for rare and hard-to-treat diseases.
Ownership category
akta.pro rank

CG Life industry classification

Industry
Product category
Life Sciences Marketing Services
NAICS
Advertising Agencies (541810), Advertising, Public Relations, and Related Services (5418)
akta.pro industry
PRIMARYMPAAADAD
Healthcare & Life Sciences PR
Media, Entertainment & Sports/Advertising, Marketing & PR Services/Public Relations & Communications Agencies
SECONDARYBPAFADAJ
Healthcare & Life Sciences PR

Keywords

  • Life sciences marketing
  • Biotech communications
  • Rare disease branding
  • Pharmaceutical marketing
  • Healthcare public relations

Where CG Life is headquartered

Location

Headquarters

HQ city
Chicago
HQ country
United States
HQ region
North America

Offices3 records

Markets served

CG Life business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Marketing Communications Services: CG Life generates revenue through providing integrated marketing communications services to life sciences companies. Services include brand strategy, public relations, social media, creative development, omnichannel strategy, scientific communications, media planning, and analytics. Revenue is generated through project-based engagements, retainer agreements, and hourly consulting fees typical of professional services agencies serving the biopharmaceutical industry.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractProfessional agency services for life sciences clients

Go-to-market motion2 records

Distribution channels1 record

Marketing channels6 records

CG Life product offering

Product offering

Core offering

CG Life is an integrated marketing communications agency that provides branding, public relations, social media, creative development, omnichannel strategy, scientific communications, media planning, and analytics services to biotech and pharmaceutical companies specializing in rare and hard-to-treat diseases. The agency guides precision medicine innovators from clinical development through commercial launch with deep scientific expertise embedded across its service delivery.

Product overview

CG Life is a life sciences marketing agency specialized for rare and hard-to-treat diseases, offering integrated marketing communications services. The agency's portfolio consists of seven core service offerings: Brand Strategy, Public Relations & Social Media, Creative, Omnichannel Strategy & Enablement, Scientific Communications, Media Planning, and Analytics & Insights. These services work together to help biotech and pharmaceutical companies navigate the path from clinical development to commercial launch. The agency has also developed the 24/364 Brand Platform, a cultural initiative featuring storytelling and films to maintain year-round visibility for rare diseases. CG Life has expanded its capabilities through strategic acquisitions of Berry & Company Public Relations (healthcare communications) and Toolhouse (digital marketing for biopharma), integrating them into its service delivery model.

Differentiator

Problem solved

Functional benefit

Brands

  • 24/364: A cultural brand platform created by CG Life to drive rare disease awareness, connection, and action year-round, featuring storytelling, films, and a film festival.

Companies that use CG Life

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

CG Life technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

CG Life partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • American Biotech Innovation Alliance (ABIA)coreStrategic or Co-development Partner · 1 May 2026CG Life is a founding member of the American Biotech Innovation Alliance (ABIA), joining biotechnology leaders from across the country to define a long-term national strategy to sustain and extend U.S. leadership in global biotech innovation. CG Life supported the alliance's launch through strategic communications and contributes to collaborative efforts shaping biotech policy and innovation strategy.

Scale indicators4 records

Recent moves10 records

Expansion highlights5 records

CG Life competitors and assessment

Company assessment

Market position

Strengths1 record

Weaknesses5 records

Competitive moat4 records

Customer concentration

CG Life social profiles

Digital presence

CG Life financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CG Life leadership team

Management profile

Number of profiles

Profiles17 records

CG Life subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

CG Life funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CG Life M&A and investment

M&A and investment

M&A5 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CG Life

What does CG Life do?

CG Life is an integrated marketing communications agency that provides branding, public relations, social media, creative development, omnichannel strategy, scientific communications, media planning, and analytics services to biotech and pharmaceutical companies specializing in rare and hard-to-treat diseases. The agency guides precision medicine innovators from clinical development through commercial launch with deep scientific expertise embedded across its service delivery.

Is CG Life a public or private company?

CG Life is a private company. It is classified as private equity controlled and is currently operating.

When was CG Life founded?

CG Life was founded in 2000. It employs 101 to 250 people.

Where is CG Life based?

CG Life is headquartered in Chicago, United States, in the North America region.

How does CG Life make money?

One revenue line is on record: marketing Communications Services.

Does CG Life have an API?

No public API is recorded for CG Life.

What industry is CG Life in?

CG Life's product category is Life Sciences Marketing Services. Its primary akta.pro industry code is MPAAADAD, Healthcare & Life Sciences PR, with a secondary code of BPAFADAJ, Healthcare & Life Sciences PR. Its NAICS code is 541810.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
CglifeCG Life Combines With AI-Native Agency The Considered to Create a New Model of Commercialization PartnerCG Life acquired AI-native pharma agency The Considered+AI to combine rare disease expertise with AI-driven commercialization. The union aims to accelerate decision-making and support smaller senior teams, with Hunt remaining CEO and a major shareholder. Terms were not disclosed.citybizCG Life Makes 2026 Inc. 5000 Following Expansion in Pharma CommercializationCG Life has been named to the 2026 Inc. 5000 list, recognizing its growth following a recent combination with AI-native pharma agency The Considered+AI. This strategic acquisition adds technology capabilities to support complex drug launches for biopharmaceutical clients. The recognition highlights the company's expansion in commercialization strategies for rare and specialty diseases.AijournCG Life Named to the 2026 Inc. 5000 List of America’s Fastest-Growing Private CompaniesCG Life has been named to the 2026 Inc. 5000 list, recognizing it as one of America’s fastest-growing private companies based on sustained revenue growth over three years. This recognition follows the agency's recent merger with AI-native pharma agency The Considered+AI, a move intended to combine scientific expertise with an AI-native operating model to accelerate therapy commercialization.Business Wire BlogCG Life Named to the 2026 Inc. 5000 List of America’s Fastest-Growing Private CompaniesCG Life has been recognized in the 2026 Inc. 5000 list as one of America's fastest-growing private companies, reflecting its continuous growth and strategic expansion. The recognition comes shortly after CG Life combined with AI-native agency The Considered+AI to enhance its role in bringing therapies for rare and hard-to-treat diseases to market. This honor validates CG Life's investment approach and effectiveness in adapting to the evolving life sciences landscape.MorningstarCG Life Named to the 2026 Inc. 5000 List of America’s Fastest-Growing Private CompaniesCG Life was named to the 2026 Inc. 5000 list of America's fastest-growing private companies. The recognition follows its merger with AI-native pharma agency The Considered+AI, combining scientific expertise and an AI-native operating model. The agency, founded in 2003, focuses on commercializing therapies for rare and hard-to-treat diseases.FiercePharmaLights, camera, action: CG Life to spotlight rare disease in dedicated film festivalCG Life announced the inaugural 24/364 Rare Disease Film Festival, scheduled for March 12-13 next year in San Diego, which will feature film screenings, panel discussions, and advocacy programming dedicated to the rare disease community. The company launched its 24/364 platform earlier this year to provide year-round attention to rare diseases affecting approximately 300 million people worldwide, complementing the single annual Rare Disease Day. The festival is currently accepting film submissions from professional and amateur filmmakers, creators, patients, caregivers, advocates, and storytellers focused on the lived experiences of rare disease patients.Business Wire Blog24/364 Rare Disease Film Festival to Debut in San Diego, Inviting Audiences to See Life Beyond the DiseaseCG Life and 24/364 have launched the inaugural 24/364 Rare Disease Film Festival, a two-day cultural event scheduled for March 12-13, 2027, in San Diego, dedicated to amplifying voices of people living with rare diseases. The festival will feature film screenings, panel discussions, networking events, and awards presentations, and is now accepting submissions from professional and amateur filmmakers, patients, caregivers, advocates, and community storytellers. The initiative represents CG Life's broader effort to create year-round visibility for rare disease experiences beyond traditional awareness campaigns.FiercePharmaCG Life appoints Collette Douaihy as chief creative officer as C-suite buildout continuesCG Life appointed Collette Douaihy as chief creative officer, bringing her 26+ years of experience from Dentsu, Evoke, and Digitas. The move accompanies the promotion of Chris Weber to chief strategy officer, expanding the agency's C-suite. CG Life also acquired Toolhouse and Berry & Company Public Relations in 2024.citybizCoco Douaihy Joins CG Life as Chief Creative Officer as Agency Expands Rare Disease Commercialization StrategyCG Life appointed Collette 'Coco' Douaihy as chief creative officer and promoted Chris Weber to chief strategy officer, strengthening the agency's leadership as it expands its rare disease and specialty biopharma commercialization strategy. Douaihy brings over 25 years of healthcare marketing experience, most recently serving as global chief creative officer for health at Dentsu International, and previously held leadership roles at Evoke and Digitas Health. The leadership expansion reflects growing demand from biotech and pharmaceutical companies for specialized commercialization support as rare disease launches become increasingly competitive and complex.Business Wire BlogCG Life Appoints Coco Douaihy as Chief Creative Officer to Drive Agency’s Creative Vision and StrategyCG Life appointed Collette Douaihy as Chief Creative Officer and promoted Chris Weber to Chief Strategy Officer. Douaihy brings over 26 years of experience, including roles at Dentsu and Digitas Health. The moves aim to enhance creative and strategic capabilities for biopharma clients.